JP2012517239A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012517239A5 JP2012517239A5 JP2011550155A JP2011550155A JP2012517239A5 JP 2012517239 A5 JP2012517239 A5 JP 2012517239A5 JP 2011550155 A JP2011550155 A JP 2011550155A JP 2011550155 A JP2011550155 A JP 2011550155A JP 2012517239 A5 JP2012517239 A5 JP 2012517239A5
- Authority
- JP
- Japan
- Prior art keywords
- influenza virus
- virus
- reassortant influenza
- donor viruses
- reassortant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000700605 Viruses Species 0.000 claims 14
- 241000712461 unidentified influenza virus Species 0.000 claims 14
- 229920001184 polypeptide Polymers 0.000 claims 7
- 125000003275 alpha amino acid group Chemical group 0.000 claims 4
- 239000000427 antigen Substances 0.000 claims 4
- 102000038129 antigens Human genes 0.000 claims 4
- 108091007172 antigens Proteins 0.000 claims 4
- 238000004519 manufacturing process Methods 0.000 claims 3
- 229960005486 vaccines Drugs 0.000 claims 3
- 206010047461 Viral infection Diseases 0.000 claims 2
- 208000001756 Virus Disease Diseases 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 230000028993 immune response Effects 0.000 claims 2
- 230000002163 immunogen Effects 0.000 claims 2
- 230000017613 viral reproduction Effects 0.000 claims 2
- 210000000987 Immune System Anatomy 0.000 claims 1
- 230000002238 attenuated Effects 0.000 claims 1
- 239000000969 carrier Substances 0.000 claims 1
- 238000004113 cell culture Methods 0.000 claims 1
- 230000000875 corresponding Effects 0.000 claims 1
- 230000004301 light adaptation Effects 0.000 claims 1
- 229960001226 live attenuated influenza Drugs 0.000 claims 1
- 229920000023 polynucleotide Polymers 0.000 claims 1
- 239000002157 polynucleotide Substances 0.000 claims 1
- 230000003449 preventive Effects 0.000 claims 1
- 230000001681 protective Effects 0.000 claims 1
- 230000035945 sensitivity Effects 0.000 claims 1
- 230000001225 therapeutic Effects 0.000 claims 1
- 210000000605 viral structures Anatomy 0.000 claims 1
Claims (16)
- 6:2再集合体インフルエンザウイルスであって、前記ウイルスが、1以上のドナーウイルス由来の6つの内部ゲノムセグメントならびにHAポリペプチドおよびNAポリペプチドをコードする2つのゲノムセグメントを含み、ここでHAポリペプチドは配列番号6のアミノ酸配列を含む前記ウイルス。
- NAポリペプチドが配列番号8のアミノ酸配列を含む、請求項1に記載の再集合体インフルエンザウイルス。
- 前記1以上のドナーウイルスがA/Ann Arbor/6/60を含む、請求項1に記載の再集合体インフルエンザウイルス。
- 前記1以上のドナーウイルスがA/Ann Arbor/6/60ではないウイルスを含む、請求項1に記載の再集合体インフルエンザウイルス。
- 前記1以上のドナーウイルスがPR8またはA/Leningrad/17である、請求項4に記載の再集合体インフルエンザウイルス。
- 前記1以上のドナーウイルスが、弱毒化、低温適合化、および温度感受性からなる群より選択される1以上の表現型について選択される、請求項1または2に記載の再集合体インフルエンザウイルス。
- 免疫学的に効果的な量の、請求項6に記載の再集合体インフルエンザウイルスを含む免疫原性組成物。
- 個体に免疫学的に効果的な量で生理学的に効果的な担体中で投与したときに、免疫系を刺激してインフルエンザウイルスに対する保護的な免疫応答を生じる医薬の製造のための、請求項6に記載の再集合体インフルエンザウイルスの使用。
- 個体に効果的な量で投与したときに、ウイルス感染の予防的または治療的処置のためのウイルス感染に対する免疫応答を生じる医薬の製造のための、請求項6に記載の再集合体インフルエンザウイルスの使用。
- 請求項7に記載の免疫原性組成物を含む、生弱毒化インフルエンザワクチン。
- 免疫学的に効果的な量の請求項1に記載の再集合体ウイルスを含む、ウイルス成分ワクチンまたは死滅ウイルスワクチン。
- 細胞培養において再集合体インフルエンザウイルスを製造する方法であって、
i) インフルエンザウイルスの複製を支持する能力を有する宿主細胞の集団に、インフルエンザウイルスゲノムに対応するポリヌクレオチドを含む複数のベクターを導入すること、
ここで該複数のベクターは、1以上のドナーウイルスの少なくとも6つの内部ゲノムセグメント、および2つの表面抗原ゲノムセグメントを含み、ここで該2つの表面抗原ゲノムセグメントは、HAおよびNAポリペプチドをコードし、HAポリペプチドをコードする表面抗原ゲノムセグメントは配列番号6のアミノ酸配列を含むポリペプチドを生じるものである、
ii) 前記宿主細胞の集団を培養すること、および
iii) 前記複数のインフルエンザウイルスを回収すること、
を含む前記方法。 - NAポリペプチドをコードする表面抗原ゲノムセグメントが、配列番号8に記載のアミノ酸配列を含むポリペプチドを生じるものである、請求項12に記載の方法。
- 前記1以上のドナーウイルスが、弱毒化、低温適合化、および温度感受性からなる群より選択される1以上の表現型について選択される、請求項12または13に記載の方法。
- 前記1以上のドナーウイルスがA/Ann Arbor/6/60を含む、請求項12に記載の方法。
- 前記1以上のドナーウイルスがA/Ann Arbor/6/60ではないウイルスを含む、請求項12に記載の方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15209409P | 2009-02-12 | 2009-02-12 | |
US61/152,094 | 2009-02-12 | ||
PCT/US2010/022970 WO2010093537A2 (en) | 2009-02-12 | 2010-02-03 | Influenza hemagglutinin and neuraminidase variants |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2012517239A JP2012517239A (ja) | 2012-08-02 |
JP2012517239A5 true JP2012517239A5 (ja) | 2013-03-14 |
JP5818693B2 JP5818693B2 (ja) | 2015-11-18 |
Family
ID=42562246
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2011550155A Expired - Fee Related JP5818693B2 (ja) | 2009-02-12 | 2010-02-03 | インフルエンザ赤血球凝集素およびノイラミニダーゼ変異体 |
Country Status (11)
Country | Link |
---|---|
US (2) | US8613935B2 (ja) |
EP (1) | EP2396033B1 (ja) |
JP (1) | JP5818693B2 (ja) |
CN (1) | CN102361649A (ja) |
AU (1) | AU2010213966B2 (ja) |
BR (1) | BRPI1008549A2 (ja) |
CA (1) | CA2752205A1 (ja) |
MX (2) | MX2011008497A (ja) |
RU (2) | RU2535970C2 (ja) |
SG (2) | SG2014010185A (ja) |
WO (1) | WO2010093537A2 (ja) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005116258A2 (en) | 2004-05-25 | 2005-12-08 | Medimmune Vaccines, Inc. | Influenza hemagglutinin and neuraminidase varians |
AU2007286161B2 (en) | 2006-08-09 | 2013-05-02 | Medimmune, Llc | Influenza hemagglutinin and neuraminidase variants |
BRPI1008549A2 (pt) | 2009-02-12 | 2016-03-15 | Medimmune Llc | variantes de neuraminidase e hemaglutinina de influenza |
CA2811023A1 (en) | 2010-09-21 | 2012-03-29 | Massachusetts Institute Of Technology | Influenza treatment and/or characterization; human-adapted ha polypeptides; vaccines |
CN108103084B (zh) * | 2017-11-21 | 2020-06-26 | 浙江迪福润丝生物科技有限公司 | 区分免疫和感染动物h5亚型禽流感疫苗株及其制备方法和应用 |
Family Cites Families (51)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3992522A (en) * | 1973-01-24 | 1976-11-16 | The United States Of America As Represented By The Department Of Health, Education And Welfare | Temperature-sensitive recombinant mutant viruses and a process for producing same |
US4071618A (en) * | 1974-09-03 | 1978-01-31 | Research Foundation For Microbial Diseases Of Osaka University | Process for preparing virus disease live vaccines |
JPS57136528A (en) * | 1981-02-09 | 1982-08-23 | Hayashibara Biochem Lab Inc | Preparation of viral vaccine |
CH652145A5 (de) | 1982-01-22 | 1985-10-31 | Sandoz Ag | Verfahren zur in vitro-herstellung von hybridomen welche humane monoklonale antikoerper erzeugen. |
US4634666A (en) * | 1984-01-06 | 1987-01-06 | The Board Of Trustees Of The Leland Stanford Junior University | Human-murine hybridoma fusion partner |
US4752473A (en) * | 1984-10-12 | 1988-06-21 | The Regents Of The University Of California | Expression of glycosylated human influenza hemagglutinin proteins |
US5202238A (en) | 1987-10-27 | 1993-04-13 | Oncogen | Production of chimeric antibodies by homologous recombination |
US5840520A (en) * | 1989-08-28 | 1998-11-24 | Aviron | Recombinant negative strand RNA virus expression systems |
US5166057A (en) | 1989-08-28 | 1992-11-24 | The Mount Sinai School Of Medicine Of The City University Of New York | Recombinant negative strand rna virus expression-systems |
US5854037A (en) * | 1989-08-28 | 1998-12-29 | The Mount Sinai School Of Medicine Of The City University Of New York | Recombinant negative strand RNA virus expression systems and vaccines |
US6001634A (en) * | 1989-08-28 | 1999-12-14 | Palese; Peter | Recombinant negative strand RNA viruses |
US5665362A (en) * | 1990-09-25 | 1997-09-09 | Cantab Pharmaceuticals Research Limited | Viral vaccines |
ES2247584T3 (es) | 1992-04-14 | 2006-03-01 | The Mount Sinai School Of Medicine Of The City University Of New York | Virus atenuados por ingenieria genetica. |
IL105456A (en) * | 1992-04-21 | 1996-12-05 | American Home Prod | Vaccines of attenuated respiratory syncytial virus |
EP0702085B2 (en) * | 1994-07-18 | 2010-01-13 | Conzelmann, Karl-Klaus, Prof. Dr. | Recombinant infectious non-segmented negative strand RNA virus |
US5789229A (en) * | 1994-09-30 | 1998-08-04 | Uab Research Foundation | Stranded RNA virus particles |
US5716821A (en) * | 1994-09-30 | 1998-02-10 | Uab Research Foundation | Prevention and treatment of respiratory tract disease |
US5756341A (en) * | 1994-11-10 | 1998-05-26 | Immuno Ag | Method for controlling the infectivity of viruses |
US6146873A (en) * | 1994-11-10 | 2000-11-14 | Baxter Aktiengesellschaft | Production of orthomyxoviruses in monkey kidney cells using protein-free media |
US7153510B1 (en) * | 1995-05-04 | 2006-12-26 | Yale University | Recombinant vesiculoviruses and their uses |
US5690937A (en) | 1995-06-05 | 1997-11-25 | Aviron | Temperature sensitive clustered changed-to-alanine mutants of influenza virus PB2 gene |
EP0780475B2 (en) | 1995-08-09 | 2006-07-19 | SCHWEIZ. SERUM- & IMPFINSTITUT BERN | Process for the production of infectious negative-strand RNA viruses |
US6264957B1 (en) | 1995-09-27 | 2001-07-24 | The United States Of America As Represented By The Department Of Health And Human Services | Product of infectious respiratory syncytial virus from cloned nucleotide sequences |
WO1997016538A1 (fr) | 1995-10-31 | 1997-05-09 | Dnavec Research Inc. | Vecteur de virus d'arn a brin negatif possedant une activite de replication autonome |
CA2236378C (en) | 1995-11-01 | 2011-01-25 | Dnavec Research Inc. | Recombinant sendai virus |
US6090391A (en) * | 1996-02-23 | 2000-07-18 | Aviron | Recombinant tryptophan mutants of influenza |
ES2345643T3 (es) | 1996-07-15 | 2010-09-28 | The Government Of The Usa, As Represented By The Department Of Health And Human Services | Produccion de vacunas a base de virus respiratorio sincitial atenuado, a partir de secuencias nucleotidicas clonadas. |
BR9712138A (pt) | 1996-09-27 | 2000-01-18 | American Cyanamid Co | Vìrus de rna isolado, vacina, processo para imunizr um indivìduo para induzir proteção contra um vìrus de rna não segmentado, sentido negativo, de filamento único, da ordem mononegavirales e para produzir vìrus de rna, molécula de ácido nucleico isolada e composição. |
EP0994949B1 (en) | 1997-05-23 | 2011-03-09 | THE UNITED STATES OF AMERICA, as represented by the Secretary of the Department of Health and Human Services | Production of attenuated parainfluenza virus vaccines from cloned nucleotide sequences |
WO1999002657A1 (en) | 1997-07-11 | 1999-01-21 | Yale University | Rhabdoviruses with reengineered coats |
KR20010030630A (ko) | 1997-09-19 | 2001-04-16 | 윌리암 에이취 캘넌, 에곤 이 버그 | 약독화 호흡 신시티아 바이러스 |
US6146642A (en) * | 1998-09-14 | 2000-11-14 | Mount Sinai School Of Medicine, Of The City University Of New York | Recombinant new castle disease virus RNA expression systems and vaccines |
EP1035209A1 (en) | 1999-03-06 | 2000-09-13 | ARTEMIS Pharmaceuticals GmbH | Stable recombinant influenza viruses free of helper viruses |
US8715940B2 (en) * | 1999-04-06 | 2014-05-06 | Wisconsin Alumni Research Foundation | Method of making recombinant influenza virus |
CN1350578B (zh) | 1999-04-06 | 2010-05-12 | 威斯康星校友研究基金会 | 用于疫苗和基因治疗的重组流感病毒 |
AU2001250352B2 (en) | 2000-03-02 | 2006-01-12 | Polymun Scientific Immunbiologische Forschung Gmbh | Recombinant influenza a viruses |
PT1317559E (pt) | 2000-04-28 | 2009-02-12 | St Jude Childrens Res Hospital | Sistema de transfecção de adn para a produção de vírus infecciosos de arn de cadeia negativa |
CA2423038C (en) | 2000-09-25 | 2012-03-13 | Polymun Scientific Immunbiologische Forschung Gmbh | Live vaccine and method of manufacture |
USPP15035P3 (en) * | 2001-06-27 | 2004-07-27 | Marko Zaninovich, Inc. | Grapevine ‘12-76-71’ |
KR100600988B1 (ko) * | 2002-03-13 | 2006-07-13 | 주식회사 엘지생명과학 | Dna 면역화에서 인플루엔자 np 유전자 dna를 함께투여하여 면역반응을 증가시키는 방법 |
US7465456B2 (en) * | 2002-04-26 | 2008-12-16 | Medimmune, Llc | Multi plasmid system for the production of influenza virus |
CN1678345B (zh) * | 2002-04-26 | 2013-09-11 | 米迪缪尼有限公司 | 制备流感病毒的多质粒系统 |
EP2581093B1 (en) * | 2003-06-16 | 2015-03-18 | MedImmune, LLC | Influenza hemagglutinin and neuraminidase variants |
US7037707B2 (en) * | 2003-09-04 | 2006-05-02 | St. Jude Children's Research Hospital | Method for generating influenza viruses and vaccines |
WO2005116258A2 (en) * | 2004-05-25 | 2005-12-08 | Medimmune Vaccines, Inc. | Influenza hemagglutinin and neuraminidase varians |
US8043813B2 (en) | 2004-11-01 | 2011-10-25 | Japan As Represented By Director-General Of National Institute Of Infectious Diseases | Method of detecting H5 or H7 avian influenza virus |
EP1856271A4 (en) * | 2005-03-08 | 2009-11-18 | Medimmune Vaccines Inc | INFLUENZA HEMAGGLUTININE AND NEURAMINIDASE VARIANTS |
RU2315101C2 (ru) * | 2006-01-10 | 2008-01-20 | ГУ "Научно-исследовательский институт экспериментальной медицины "Российской Академии медицинских наук (ГУ НИИЭМ РАМН) | Вакцинный штамм вируса гриппа а/17/калифорния/ 04/6 (н3n2) и донор аттенуации а/ленинград/134/17/к7/57 (н2n2) для его получения |
AU2007286161B2 (en) * | 2006-08-09 | 2013-05-02 | Medimmune, Llc | Influenza hemagglutinin and neuraminidase variants |
US8084594B2 (en) * | 2007-07-13 | 2011-12-27 | The United States Of America As Represented By The Secretary Of Agriculture | H2N3 influenza A viruses and methods of use |
BRPI1008549A2 (pt) | 2009-02-12 | 2016-03-15 | Medimmune Llc | variantes de neuraminidase e hemaglutinina de influenza |
-
2010
- 2010-02-03 BR BRPI1008549A patent/BRPI1008549A2/pt not_active IP Right Cessation
- 2010-02-03 CA CA 2752205 patent/CA2752205A1/en not_active Abandoned
- 2010-02-03 EP EP10741567.1A patent/EP2396033B1/en not_active Not-in-force
- 2010-02-03 CN CN2010800138806A patent/CN102361649A/zh active Pending
- 2010-02-03 RU RU2011137404/10A patent/RU2535970C2/ru not_active IP Right Cessation
- 2010-02-03 MX MX2011008497A patent/MX2011008497A/es active IP Right Grant
- 2010-02-03 WO PCT/US2010/022970 patent/WO2010093537A2/en active Application Filing
- 2010-02-03 JP JP2011550155A patent/JP5818693B2/ja not_active Expired - Fee Related
- 2010-02-03 SG SG2014010185A patent/SG2014010185A/en unknown
- 2010-02-03 AU AU2010213966A patent/AU2010213966B2/en not_active Ceased
- 2010-02-03 SG SG2011057791A patent/SG173642A1/en unknown
- 2010-02-03 US US12/699,108 patent/US8613935B2/en not_active Expired - Fee Related
-
2011
- 2011-08-11 MX MX2013015094A patent/MX343411B/es unknown
-
2013
- 2013-11-21 US US14/086,902 patent/US9119812B2/en not_active Expired - Fee Related
-
2014
- 2014-10-08 RU RU2014140731A patent/RU2014140731A/ru not_active Application Discontinuation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Chen et al. | Advances in development and application of influenza vaccines | |
Begum et al. | Challenges and prospects of COVID‐19 vaccine development based on the progress made in SARS and MERS vaccine development | |
Alkie et al. | Infectious bursal disease virus in poultry: current status and future prospects | |
Kamel et al. | Foot-and-mouth disease vaccines: recent updates and future perspectives | |
RU2011104999A (ru) | Варианты гемагглютинина и нейрамидазы вируса гриппа | |
CN101636177A (zh) | 用于禽流感的基于重组改良型痘苗病毒安卡拉(mva)的疫苗 | |
JP2014534202A5 (ja) | ||
NZ596823A (en) | Swine influenza hemagglutinin variants | |
Jang et al. | Principles underlying rational design of live attenuated influenza vaccines | |
JP2017502662A5 (ja) | ||
Yi et al. | Molecular characterization of a virulent genotype VIId strain of Newcastle disease virus from farmed chickens in Shanghai | |
JP2012517239A5 (ja) | ||
RU2014140731A (ru) | Варианты гемагглютинина и нейраминидазы гриппа | |
CN108456663A (zh) | 一种1型牛病毒性腹泻病毒样颗粒及其制备与应用 | |
KR20200085135A (ko) | H5N8형 재조합 인플루엔자 A 바이러스 및 이를 포함하는 clade 2.3.4.4A에 속하는 H5 혈청형 인플루엔자 A 바이러스에 대한 백신 조성물 | |
RU2018130683A (ru) | Аттенуированный вирус инфекционного бронхита | |
JP2014139185A5 (ja) | ||
CN103627718A (zh) | 表达ibv s1和n双抗原蛋白重组质粒及其构建方法和应用 | |
EP2716752A1 (en) | Canine influenza recombinant virus, preparation method therefor and application thereof | |
Kapczynski et al. | Immunization of turkeys with a DNA vaccine expressing either the F or N gene of avian metapneumovirus | |
Lee et al. | Genetic evolution of H5 highly pathogenic avian influenza virus in domestic poultry in Vietnam between 2011 and 2013 | |
CN101942011A (zh) | 人3型、7型腺病毒的中和抗原表位及其应用 | |
JP2014502143A5 (ja) | ||
Adler et al. | A non-transmissible live attenuated SARS-CoV-2 vaccine | |
Balamurugan et al. | Past and present vaccine development strategies for the control of foot-and-mouth disease |